Cardiovascular disease after menopause: a growing epidemic

Area of Science:

• Cardiovascular Science
• Endocrinology
• Women's Health

Background:

• Coronary heart disease (CHD) is the primary cause of mortality in postmenopausal women.
• Menopause is associated with changes in risk factors that increase CHD risk.
• Hormone replacement therapy has not demonstrated overall cardiovascular benefit despite improving some risk factors.

Purpose of the Study:

• To explore the connection between cardiovascular disease and metabolic syndrome in postmenopausal women.
• To investigate the role of metabolic risk factors in CHD risk for women compared to men.
• To examine the influence of C-reactive protein on CHD risk within the context of metabolic syndrome.

Main Methods:

• Observational study analyzing risk factor changes post-menopause.
• Comparison of CHD risk associated with metabolic factors in women versus men.
• Assessment of C-reactive protein's impact on metabolic syndrome and CHD risk.

Main Results:

• Postmenopausal women face increased CHD risk due to altered metabolic profiles.
• Metabolic risk factors like high triglycerides, low HDL-cholesterol, and glucose abnormalities may pose a greater CHD risk in women.
• C-reactive protein appears to modify CHD risk across all levels of metabolic syndrome.

Conclusions:

• A strong link exists between cardiovascular disease and metabolic syndrome in postmenopausal women.
• Metabolic syndrome components and inflammation significantly influence CHD risk in this demographic.
• Further research is essential to develop effective strategies against cardiovascular morbidity and mortality in postmenopausal women.